Search
for
Sort by
Research 571–600 of 1000+
- Letter to the Editor Etiquette
- Cytostatics and immunosuppressive drugs
- Wound Healing: A Cellular Perspective
- Treatment of Hair Loss
- Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning
- Alopecia areata
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Dermatoses of pregnancy
- COVID-19 and Sex Differences
- Guidelines for the management of alopecia areata
- The pharmacology of methotrexate
- Epidemiology and burden of alopecia areata: a systematic review
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Dermatological adverse events with taxane chemotherapy
- Exosomes for repair, regeneration and rejuvenation
- Cutaneous reactions to recombinant cytokine therapy
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Female pattern hair loss
- The blastema and epimorphic regeneration in mammals
- Drug Reactions Affecting Hair: Diagnosis
- Management of Hair Loss
- Cutaneous lupus erythematosus
- Improving stable isotopic interpretations made from human hair through reduction of growth cycle error
- Physiological and biological skin changes in pregnancy
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Primary cicatricial alopecia
- Strategies to enhance epithelial–mesenchymal interactions for human hair follicle bioengineering
- Histologic features of alopecia areata other than peribulbar lymphocytic infiltrates